Morgan Stanley’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $4.61K | Buy |
|
|||||
|
2022
Q4 | $9.85K | Buy |
|
|||||
|
2022
Q3 | $10K | Sell |
|
|||||
|
2022
Q2 | $12K | Sell |
|
|||||
|
2022
Q1 | $22K | Buy |
|
|||||
|
2021
Q4 | $8K | Sell |
|
|||||
|
2021
Q3 | $16K | Buy |
|
|||||
|
2021
Q2 | $16K | Buy |
|
|||||
|
2021
Q1 | $3K | Sell |
|
|||||
|
2020
Q4 | $11K | Sell |
|
|||||
|
2020
Q3 | $20K | Buy |
|
|||||
|
2020
Q2 | $7K | Sell |
|
|||||
|
2020
Q1 | $116K | Buy |
|
|||||
|
2019
Q4 | $78K | Buy |
|
|||||
|
2019
Q3 | $10K | Sell |
|
|||||
|
2019
Q2 | $445K | Sell |
|
|||||
|
2019
Q1 | $975K | Sell |
|
|||||
|
2018
Q4 | $1.01M | Sell |
|
|||||
|
2018
Q3 | $2.17M | Sell |
|
|||||
|
2018
Q2 | $2.79M | Buy |
|
|||||
|
2018
Q1 | $2.38M | Buy |
|
|||||
|
2017
Q4 | $2.13M | Sell |
|
|||||
|
2017
Q3 | $4.28M | Buy |
|
|||||
|
2017
Q2 | $2.91M | Sell |
|
|||||
|
2017
Q1 | $4.62M | Sell |
|
|||||
|
2016
Q4 | $5.86M | Sell |
|
|||||
|
2016
Q3 | $8.79M | Buy |
|
|||||
|
2016
Q2 | $5.34M | Sell |
|
|||||
|
2016
Q1 | $3.87M | Sell |
|
|||||
|
2015
Q4 | $8.65M | Buy |
|
|||||
|
2015
Q3 | $5.12M | Buy |
|
|||||
|
2015
Q2 | $818K | Buy |
|
|||||
|
2015
Q1 | $777K | Sell |
|
|||||
|
2014
Q4 | $3.46M | Buy |
|